Politics Weight loss drugs pose risk to pharma, report finds Finance News May 4, 2026 Surging demand for weight loss and diabetes drugs leaves the pharmaceutical sector at risk from a "bubble effect" as… Read More...
Politics Lp(a) drugs from Novartis, Amgen and Eli Lilly aim to prevent heart attacks Finance News Apr 27, 2026 Pharma thinks it's found the next frontier in preventing heart attacks. Novartis, Amgen and Eli Lilly are among the… Read More...
Politics European pharma jeopardized by Trump policies, China’s biotech boom Finance News Apr 10, 2026 Boxes of medication are seen on the shelves of the Keencare pharmacy, a member of the Green Light Group, on September… Read More...
Politics Novartis shells out $2 billion for immunology biotech Excellergy Finance News Mar 27, 2026 A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern… Read More...
Business Pfizer Lyme disease vaccine fails trial, company to seek FDA approval Finance News Mar 23, 2026 Thomas Fuller | Nurphoto | Getty ImagesPfizer on Monday said it will seek regulatory approval for a Lyme disease… Read More...
Business FDA vaccine head will step down in April after string of controversial Finance News Mar 8, 2026 The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services… Read More...
Politics Zealand stock falls 35% after trial setback, CEO remains optimistic Finance News Mar 6, 2026 Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight… Read More...
Politics These 4 charts show the scale of Novo Nordisk’s woes Finance News Feb 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe's most valuable company.But… Read More...
Politics Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly Finance News Feb 23, 2026 The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |… Read More...